RecruitingNCT05935683

Rhinosinusitis Italian Network: the Italian Registry for Severe, Uncontrolled Chronic Rhinosinusitis

Rhinosinusitis Italian Network (RINET): the Italian Registry for Severe, Uncontrolled Chronic Rhinosinusitis


Sponsor

Italian Academy of Rhinology

Enrollment

5,000 participants

Start Date

Nov 1, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

This observatory aims to collect, as widely as possible, the Italian cases of patients with uncontrolled CRS. Patient will be enrolled by the centers of the Italian Network of Rhinosinusitis (Rhinosinusitis Italian Network: RINET), and they will be treated using a multidisciplinary team approach (allergists, otolaryngologists and pneumologists) in a real-world clinical set-up. This real-life chronic rhinosinusitis registry aims at longitudinal data collection from patients attending specialist care centres across Italy.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Participants with a confirmed diagnosis of bilateral Chronic Rhinosinusitis that have at least three (in case of patients previously treated with surgical approaches) or four (in case of patients never treated with nasal sinus surgery) of the following criteria:
  • Evidence of type 2 inflammation (at least 250 blood eosinophils per microliter and / or at least 10 eosinophils / HPF from a histological sample of sinus mucosa and / or at least one finding of moderate eosinophilia on nasal cytology and / or total serum IgE >100 IU / ml);
  • at least two Short courses of systemic corticosteroids or lorg-term Systemic Corticosteroids therapy for Chronic Rhinosinusitis;
  • Significant deterioration in the quality of life (Sinonasal Outcome Test 22 - SNOT-22>= 40 and / or Visual Analogue Scale - Global VAS of symptoms>= 5);
  • Loss of Smell (VAS for hyposmia> = 7)

Exclusion Criteria1

  • \-

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSevere Uncontrolled Chronic Rhinosinusitis patients (CRS)

Obsertvation


Locations(1)

Personalized Medicine, Asthma and Allergy - IRCCS Humanitas Research Hospital

Rozzano, MIlan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05935683


Related Trials